Shuttle pharmaceuticals ipo
WebAug 31, 2024 · Today's IPO for Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) opened for trading at $24.05 after pricing 1,225,888 units of common stock and warrants, … WebFunding. Shuttle Pharmaceuticals has raised a total of $4.9M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2024 from a Post-IPO Debt round. Shuttle …
Shuttle pharmaceuticals ipo
Did you know?
WebApr 5, 2024 · Shuttle Pharmaceuticals Shuttle Pharmaceuticals Holdings, Inc (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focusing on cancer treatments and radiation therapy. Their Sept 2024 IPO was valued at just under $10 million at a share price of $8.125. WebJul 1, 2024 · The last biotech to go public, eye drug developer Okyo Pharma, did so in mid-May and raised less than $3 million, according to BioPharma Dive’s database. Two biotechs, Genelux and Shuttle Pharmaceuticals, have publicly outlined IPO plans since the end of April, and they’ve joined a queue of companies mostly targeting modest offerings.
WebAug 31, 2024 · Radiation therapy drug developer Shuttle Pharmaceuticals ( NASDAQ: SHPH) saw its stock soar 373% following its $10M initial public offering on Wednesday. Shares … WebAug 31, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the …
WebOn March 15, 2024 Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), reported a corporate update in connection with the filing of its Annual Report on Form 10-K for the year ended December … WebSep 1, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), which is developing drug candidates to raise the effectiveness of radiation therapy in cancer patients, lowered …
WebApr 14, 2024 · KNOT Offshore Partners (NYSE:KNOP - Get Rating) was downgraded by investment analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued on Friday.A number of other research firms also recently issued reports on KNOP. Alliance Global Partners upgraded KNOT Offshore Partners from a "sell" rating to a …
WebApr 10, 2024 · Since the IPO on August 31, 2024, Shuttle Pharmaceuticals Holdings, Inc.'s market cap has decreased from $95.65M to $18.02M, a decrease of -81.16%. That is a … cs lewis fish knivesWebJun 6, 2024 · Shuttle Pharmaceuticals Holdings ( NASDAQ: SHPH) has filed to raise $14.25 million in an IPO of its common stock, according to an S-1 registration statement. The … eaglercraft xrayWebMark is an experienced C-Level professional and the Founder & Chief Visionary Officer at NOUV, a management and financial consulting firm that offers an integrated solution across all business functions in consulting, business support and assurance services. Mark specialises in helping organisations identify, design, and execute their strategy. He has … cs lewis first bookWebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and ... c.s. lewis four loves friendship summaryWebApr 11, 2024 · Accédez à toutes les dernières informations boursières et économiques en France, aux Etats-Unis, et en Europe. eaglercraft x downloadWeb2 days ago · Shuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrants. ROCKVILLE, Md. , Jan. 12, 2024 … eaglercraft汉化版WebSep 6, 2024 · ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty … eaglercraft x